Delivery Order SPE2DR25D1106-SPE2DR26FJF2L
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 grams) with a ceiling value of $4,328.64. This firm fixed-price delivery order represents a non-competitive set-aside and is scheduled for completion by August 18, 2025, with performance occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Albuterol HFA 90 mcg inhalers (8.5 gm) valued at $1,241.52. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and carries an ultimate completion date of December 5, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Albuterol HFA 90 mcg inhalers. This firm fixed price delivery order, valued at $2,460.36, represents a non-competitive award under an existing indefinite delivery contract vehicle. The order is due for completion by October 9, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. As a child delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, valued at $1,665.03. This non-competitive, firm fixed-price delivery order will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, with a completion deadline of September 9, 2025. The award represents a continuation of AmerisourceBergen's substantial role in federal pharmaceutical procurement, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Albuterol HFA 90 MCG Inhalers (8.5 GM) with a ceiling value of $1,373.40. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is set to complete by July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls...
- The Defense Logistics Agency awarded a delivery order valued at $1,863.66 to AmerisourceBergen Drug Corp for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of July 31, 2025. The contract utilizes firm fixed pricing and was awarded without a set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for the supply of Albuterol HFA 90 mcg inhalers with a ceiling value of $2,061.12. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 8, 2025, and performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Albuterol HFA 90 MCG Inhaler in 8.5GM units, valued at $1,518.96. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $1,562.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG Inhaler 8.5GM, with an ultimate completion date of December 12, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's broader federal contract portfolio. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,849.06 to AmerisourceBergen Drug Corp for Albuterol HFA 90 MCG inhalers (8.5GM) on September 16, 2025, with completion scheduled for September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical...
- SPE2DR25D1106Indefinite Delivery Contract
- SPE2DR25D1106-SPE2DR26FJF2LDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 27, 2025, for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, with a ceiling value of $1,559.04. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is located. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, is a critical federal medical procurement vendor serving military and veteran healthcare systems through open competition. The company maintains an extensive portfolio of federal contract awards with DLA covering a wide spectrum of therapeutic domains, ranging from brand-name and generic medications to vaccines and specialized medical supplies. This delivery order for respiratory medication supports the Defense Health Agency and broader military healthcare operations through a flexible and comprehensive contract vehicle that positions AmerisourceBergen as one of multiple potential regional pharmaceutical suppliers under DLA's strategic contracting approach.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 12/26/25 |